Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients | Zendy

Michael O. Sweeney | Zendy; Mark S. Wathen | Zendy; KENT J. VOLOSIN | Zendy; Ismaile Abdalla | Zendy; Paul DeGroot | Zendy; Mary F. Otterness | Zendy; Alice J. Stark | Zendy

Open Access

Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients

Author(s) -

Michael O. Sweeney,

Mark S. Wathen,

KENT J. VOLOSIN,

Ismaile Abdalla,

Paul DeGroot,

Mary F. Otterness,

Alice J. Stark

Publication year - 2005

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.104.526673

Subject(s) - medicine , implantable cardioverter defibrillator , primary prevention , secondary prevention , intensive care medicine , quality of life (healthcare) , cardiology , sudden cardiac death , disease , nursing

Implantable cardioverter defibrillators (ICDs) reduce mortality in primary and secondary prevention. Quality of life, mortality, appropriate therapies for specific ventricular rhythms, and inappropriate therapies for supraventricular tachycardia (SVT) were compared among 582 patients (primary prevention=248; secondary prevention=334) in PainFREE Rx II, a 634-patient prospective, randomized study of antitachycardia pacing or shocks for fast ventricular tachycardia (FVT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research